Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors
The Hindu
British-Swedish pharma giant AstraZeneca and U.S. pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
Located in the city of Pune in Maharashtra, the SII is the world’s largest vaccine manufacturer by volume.
More Related News













